Literature DB >> 15561190

Antibacterial and resistance modifying activity of Rosmarinus officinalis.

Moyosoluwa Oluwatuyi1, Glenn W Kaatz, Simon Gibbons.   

Abstract

As part of a project to characterise plant-derived natural products that modulate bacterial multidrug resistance (MDR), bioassay-guided fractionation of a chloroform extract of the aerial parts of Rosmarinus officinalis led to the characterisation of the known abietane diterpenes carnosic acid (1), carnosol (2) and 12-methoxy-trans-carnosic acid. Additionally, a new diterpene, the cis A/B ring junction isomer of 12-methoxy-trans-carnosic acid, 12-methoxy-cis-carnosic acid (5), was isolated. The major components were assessed for their antibacterial activities against strains of Staphylococcus aureus possessing efflux mechanisms of resistance. Minimum inhibitory concentrations ranged from 16 to 64 microg/ml. Incorporation of 1 and 2 into the growth medium at 10 microg/ml caused a 32- and 16-fold potentiation of the activity of erythromycin against an erythromycin effluxing strain, respectively. Compound 1 was evaluated against a strain of S. aureus possessing the NorA multidrug efflux pump and was shown to inhibit ethidium bromide efflux with an IC50 of 50 microM, but this activity is likely to be related to the inhibition of a pump(s) other than NorA. The antibacterial and efflux inhibitory activities of these natural products make them interesting potential targets for synthesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561190     DOI: 10.1016/j.phytochem.2004.10.009

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  48 in total

Review 1.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

3.  Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid.

Authors:  Siva Ram Kiran Vaka; S Narasimha Murthy; Michael A Repka; Tamas Nagy
Journal:  J Pharm Sci       Date:  2011-03-01       Impact factor: 3.534

Review 4.  Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

Authors:  Bikash Baral; M R Mozafari
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-13

5.  The licorice pentacyclic triterpenoid component 18β-glycyrrhetinic acid enhances the activity of antibiotics against strains of methicillin-resistant Staphylococcus aureus.

Authors:  A de Breij; T G Karnaoukh; J Schrumpf; P S Hiemstra; P H Nibbering; J T van Dissel; P C de Visser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-15       Impact factor: 3.267

6.  Carnosic acid is an efflux pumps modulator by dissipation of the membrane potential in Enterococcus faecalis and Staphylococcus aureus.

Authors:  Adriana M Ojeda-Sana; Victoria Repetto; Silvia Moreno
Journal:  World J Microbiol Biotechnol       Date:  2012-09-08       Impact factor: 3.312

7.  Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Mastura Mohtar; Saiful Azmi Johari; Abdul Rashid Li; Mazurah Mohamed Isa; Shuhaimi Mustafa; Abdul Manaf Ali; Dayang Fredalina Basri
Journal:  Curr Microbiol       Date:  2009-05-28       Impact factor: 2.188

8.  Antibacterial Activity of Rosmarinus officinalis against Multidrug-Resistant Clinical Isolates and Meat-Borne Pathogens.

Authors:  Aseer Manilal; Kuzhunellil Raghavanpillai Sabu; Melat Woldemariam; Addis Aklilu; Gelila Biresaw; Tsegaye Yohanes; Mohammed Seid; Behailu Merdekios
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-29       Impact factor: 2.629

Review 9.  Antimicrobial Potential of Naturally Occurring Bioactive Secondary Metabolites.

Authors:  Khaled S Allemailem
Journal:  J Pharm Bioallied Sci       Date:  2021-05-26

10.  Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.

Authors:  Christina Kourtesi; Anthony R Ball; Ying-Ying Huang; Sanjay M Jachak; D Mariano A Vera; Proma Khondkar; Simon Gibbons; Michael R Hamblin; George P Tegos
Journal:  Open Microbiol J       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.